Colgate-Palmolive, US1941621039

Colgate-Palmolive stock gains 1.16 percent as Wells Fargo cuts target

Published on 10/06/2026 at 17:31 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Colgate-Palmolive stock gained 1.16 percent to USD 87.19 on October 6, 2026, while Wells Fargo cut its target to USD 90. Q2 sales rose 4.9 percent.

Schwarzweiß-Dokumentarfoto von Kunden im Supermarkt-Körperpflegegang
Colgate-Palmolive Marktpräsenz US1941621039 in schwarz-weißer Reportage von Kunden im belebten Supermarktgang für Pflegeprodukte, Illustration mit AI erstellt.

Colgate-Palmolive stock (ISIN US1941621039) gained 1.16 percent to USD 87.19 on the NYSE on October 6, 2026, at 11:30 a.m. ET. The immediate catalyst was a Wells Fargo target cut from USD 95 to USD 90 on October 5, while the bank kept its Equal Weight rating, according to MarketBeat.

Wells Fargo lowers its target

The new USD 90 target sits 3.22 percent above the October 6 price of USD 87.19. That gap is narrower than the broader analyst view, making the Wells Fargo call a more cautious counterweight to the consensus.

MarketScreener listed an Outperform mean consensus from 21 analysts, with an average target of USD 98.95 and a spread of 13.74 percent above its USD 87.00 last-close reference on September 15, 2026. The range ran from USD 87.00 to USD 110.00, leaving the consensus materially above the Wells Fargo target.

Q2 growth meets margin pressure

Colgate-Palmolive's Q2 2026 net sales rose 4.9 percent, organic sales increased 2.4 percent, and base business EPS climbed 8 percent to USD 0.99, according to Business Wire. GAAP EPS declined 5 percent to USD 0.86, showing why the stock's valuation remains sensitive to the quality of earnings growth.

The same Q2 release reported a gross profit margin of 61.5 percent, up 140 basis points, while net cash from operations reached USD 1.742 billion in the first six months of 2026. Management's operating picture therefore combines stronger adjusted profitability with restructuring effects in the GAAP result.

Q3 results set for October 30

Colgate-Palmolive is scheduled to report Q3 2026 results on October 30, 2026, according to MarketScreener. That date gives investors a defined checkpoint for testing whether the 4.9 percent Q2 sales growth and 61.5 percent margin can continue.

Colgate-Palmolive stock holds above USD 87

At USD 87.19 on October 6, 2026, Colgate-Palmolive stock stood above its USD 74.55 52-week low and below its USD 99.33 high. Its market capitalization was USD 69.8 billion, with 904,115 shares traded at the quoted time.

Colgate-Palmolive stock at a glance

  • Company: Colgate-Palmolive Company
  • ISIN: US1941621039
  • Ticker: CL
  • Trading venue: NYSE
  • Price (as of October 6, 2026, 11:30 a.m. ET): USD 87.19
  • Market capitalization: USD 69.8 billion (as of October 6, 2026)
  • 52-week range: USD 74.55-99.33 (as of October 6, 2026)
  • Sector / Industry: Consumer Defensive / Household and Personal Products

Upcoming dates for Colgate-Palmolive stock

  • October 20, 2026: Ex-dividend date for the USD 0.53 quarterly dividend
  • October 30, 2026: Q3 2026 earnings release
  • November 13, 2026: Quarterly dividend payment

More news and analyses on Colgate-Palmolive stock

Disclaimer...

en | US1941621039 | COLGATE-PALMOLIVE | boerse | 70243888 | bgmi